SelankvsThymalin

Selank is a synthetic heptapeptide based on the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg), with a stabilizing Pro-Gly-Pro extension at the C-terminus that dramatically increases its resistance to aminopeptidase degradation. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, it was designed to combine the immune-enhancing effects of tuftsin with anxiolytic and nootropic properties.

The anxiolytic mechanism involves modulation of GABAergic neurotransmission. Selank acts as an allosteric modulator of GABA-A receptors, enhancing the inhibitory effects of GABA in anxiety-related brain regions including the amygdala, hippocampus, and prefrontal cortex. This produces a benzodiazepine-like anxiolytic effect without the sedation, cognitive impairment, or addiction potential associated with benzodiazepines — because Selank modulates rather than directly activates the receptor. Additionally, Selank stabilizes enkephalins (endogenous opioid pentapeptides) by inhibiting enkephalin-degrading enzymes (aminopeptidases and enkephalinase/neprilysin), prolonging their mood-regulating and anxiolytic signaling.

The nootropic effects are mediated through neurotrophic factor upregulation. Selank increases expression of brain-derived neurotrophic factor (BDNF) in the hippocampus and prefrontal cortex, promoting dendritic branching, synaptic plasticity, and long-term potentiation — the cellular mechanisms underlying memory formation and cognitive flexibility. It also modulates serotonergic (5-HT) metabolism, altering the balance between serotonin and its metabolite 5-HIAA in key brain regions. The immunomodulatory component derives from the tuftsin core: tuftsin naturally activates monocytes and macrophages through specific receptors, enhancing phagocytic activity and modulating IL-6, TNF-α, and other cytokine production. This immune regulation occurs at sub-anxiolytic doses, suggesting it is an independent pharmacological effect. The combined anxiolytic, cognitive-enhancing, and immunomodulatory profile is unique among available peptides.

Thymalin is a complex of short peptides extracted from bovine thymus glands, representing the biologically active fraction of thymic hormones. The thymus gland is the primary organ of T-cell maturation — bone marrow-derived T-cell precursors migrate to the thymus where they undergo positive and negative selection, emerging as mature, immunocompetent CD4+ helper and CD8+ cytotoxic T cells. The thymus produces a suite of peptide hormones that guide this maturation process, and Thymalin contains a mixture of these bioactive peptides.

The peptide complex acts at multiple points in the immune system. It promotes the differentiation of pre-T cells into mature T-cell subsets, restoring the CD4/CD8 ratio toward normal values (typically 1.5-2.5:1 in healthy individuals). It enhances natural killer (NK) cell cytotoxic activity, which is critical for immune surveillance against virus-infected and neoplastic cells. It modulates cytokine production — generally promoting a balanced Th1/Th2 response rather than driving either extreme — and enhances macrophage phagocytic capacity.

The relevance to aging is direct: the thymus undergoes progressive involution (shrinkage) beginning at puberty, and by age 60-70, most thymic tissue has been replaced by fat, with minimal residual T-cell educating capacity. This thymic involution is a major driver of immunosenescence — the age-related decline in immune function that increases susceptibility to infections, cancers, and autoimmune conditions while reducing vaccine responsiveness. Thymalin aims to pharmacologically replace the thymic peptide signals lost through involution, partially restoring the immune system's ability to produce new, functional T cells. Research from the Khavinson group has reported that Thymalin treatment in elderly patients was associated with reduced mortality and improved immune markers over long-term follow-up, though these studies require independent replication in Western clinical settings.